伏丽琼;朱斌;赵芳芳;
FU Liqiong;ZHU Bin;ZHAO Fangfang;The First People's Hospital of Guangyuan;

• 1:广元市第一人民医院

摘要(Abstract)：

目的:探讨抗生素降阶梯治疗策略在新生儿感染性肺炎中的效果。方法:160例新生儿感染性肺炎患儿根据抗生素治疗策略分为降阶梯组(90例)和对照组(70例),对照组患儿给予常规抗生素方案治疗,降阶梯组患儿在常规治疗的基础上给予抗生素降阶梯策略治疗;治疗7 d后评估两组患儿的临床疗效、治疗恢复进度,并检测两组患儿的血清降钙素原(PCT)、超敏C反应蛋白(CRP)及白细胞(WBC)水平。结果:降阶梯组临床总有效率为87.78%,显著高于对照组74.29%,差异有统计学意义(P<0.05);与对照组相比,降阶梯组患儿的感染控制时间、呼吸机通气时间、ICU住院时间及抗生素使用时间均明显缩短,差异有统计学意义(P<0.05);两组患儿治疗前PCT、CRP、WBC比较,差异无统计学意义(P>0.05);治疗后,降阶梯组血清CRP、PCT水平及血液WBC计数明显低于对照组,差异有统计学意义(P<0.05)。结论:抗生素降阶梯策略治疗新生儿感染性肺炎疗效突出,可有效控制患儿病情、加快恢复进程及改善血清学感染指标。
Objective: To explore the effects of antibiotic de-escalation therapy in neonatal infectious pneumonia. Methods: 160 neonates with infective pneumonia were divided into two groups according to antibiotic treatment: de-escalation group( 90 cases) and control group( 70 cases). Children in the control group were treated with routine antibiotic regimen,and those in the de-escalation group were treated with antibiotic de-escalation therapy on the basis of routine treatment. After 7 days of treatment,the clinical efficacy and recovery progress of the two groups were evaluated,and the levels of procalcitonin,Hypersensitive C-reactive protein and white blood cell were measured. Results: The total clinical effective rate of the de-escalation group was 87. 78%,which was significantly higher than that of the control group( 74. 29%). The difference was statistically significant( P < 0. 05). Compared with the control group,the infection control time,ventilator time,ICU hospitalization time and antibiotic use time in the de-escalation group were significantly shorter than those in the control group,and the difference was statistically significant( P < 0. 05). There was no significant difference in PCT,CRP and WBC between the two groups before treatment( P > 0. 05). After treatment,the level of serum CRP and PCT and the blood WBC count in the de-escalation group were significantly lower than those in the control group,and the difference was statistically significant( P < 0. 05). Conclusions: The antibiotic de-escalation therapy is effective in the treatment of infective pneumonia in newborns. It can effectively control the patient's condition,accelerate the process of recovery and improve the index of serological infection.

关键词(KeyWords)： 抗生素;新生儿;感染性肺炎;降阶梯策略
antibiotics;neonate;infectious pneumonia;de-escalation strategy

Abstract:

Keywords:

基金项目(Foundation): 四川省卫生和计划生育委员会科研课题(1401722)

作者(Author): 伏丽琼;朱斌;赵芳芳;
FU Liqiong;ZHU Bin;ZHAO Fangfang;The First People's Hospital of Guangyuan;

Email:

DOI: 10.19367/j.cnki.1000-2707.2018.04.017

参考文献(References)：

• [1]张琼燕,陈兴月,傅海鸥,等.抗菌药物对感染性肺炎新生儿的疗效及肠道微生态的影响分析[J].中华医院感染学杂志,2016,26(20):4732-4734.
• [2]齐忻.药敏实验指导治疗婴幼儿川崎病合并肺炎支原体感染[J].贵阳医学院学报,2016,41(3):356-358.
• [3]江玉凤,陈敏利,符慧玉,等.新生儿感染性肺炎危险因素分析与预防措施[J].中华医院感染学杂志,2016,26(6):1387-1389.
• [4]邵肖梅,叶鸿瑁,丘小汕.实用新生儿学[M].4版.北京:人民卫生出版社,2011:31.
• [5]曹江红,李光辉.美国感染病学会和美国胸科学会2016年成人医院获得性肺炎和呼吸机相关性肺炎的处理临床实践指南[J].中国感染与化疗杂志,2017,17(2):209-214.
• [6]夏晓文,邵小燕,李永红.新生儿细菌感染性肺炎的病原菌分布及耐药性分析[J].西部医学,2015,27(5):709-711.
• [7]李雷清,韩国丽,吴丹梅,等.重症监护病房抗菌药物降阶梯治疗策略实施情况调查[J].中华临床感染病杂志,2015,8(1):31-35.
• [8]姜毅,夏利平.儿童感染性疾病的治疗对策[J].中华实用儿科临床杂志,2015,30(10):726-729.
• [9]左满凤,舒琼璋,钟新,等.PICU脑性瘫痪重症肺炎婴幼儿亚胺培南降阶梯治疗疗效分析[J].中华医院感染学杂志,2016,26(2):432-434.
• [10]尹维红.抗生素降阶梯治疗小儿重症肺炎疗效观察探讨[J].中国医药导刊,2017,19(2):163-164.
• [11]田沁.抗生素降阶梯疗法在重症肺炎患儿中的临床效果及安全性分析[J].临床肺科杂志,2016,21(6):1038-1040.
• [12]李兆娜,王萍,寇晨,等.头孢吡肟治疗新生儿感染性肺炎119例临床分析[J].中国临床医生杂志,2015,43(5):81-83.
• [13]李建华,姜晓云.新生儿感染性肺炎中降钙素原、超敏C反应蛋白和白细胞的表达及三者联合检测的诊断价值[J].中国妇幼保健,2015,30(30):5204-5205.
• [14]李华,刘畅.抗生素降阶梯治疗重症肺炎的临床疗效及安全性[J].海南医学,2016,27(11):1773-1775.
• [15]刘蕊.抗生素降阶梯方案与传统抗生素方案治疗重症肺炎患者的临床疗效及安全性[J].中国药物经济学,2017,12(3):38-40.

文章评论(Comment)：